Market Survey on Patient Transportation Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Patient Transportation Market including Emergency, Non-Emergency, and Non-Medical Transportation Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Patient Transportation Market Outlook (2022 to 2032)
[250 Pages Report] The global patient transportation market is projected to reach a valuation of US$ 19.7 Million in 2022. Increasing investments in the healthcare sector across various countries will steer sales in the market at a 5.9% CAGR, pushing the market size to US$ 35.1 Billion by 2032.
Data Points
Market Insights
Patient Transportation Market Value (2021)
US$ 18.6 Million
Patient Transportation Market Estimated Value (2022)
US$ 19.7 Million
Patient Transportation Market Projected Value (2032)
US$ 35.1 Million
Patient Transportation Market Value-based CAGR (2022 to 2032)
5.9%
Patient Transportation Market Share of Top 5 Countries
55.4%
Patient transportation products (equipment and tools) assist individuals with disease indications that may render their mobility compromised. These products are used to improve the accessibility of healthcare services and interventions among the inflicted, diseased and elderly population who are reliant on healthcare providers and guardians or require medical transportation during emergencies.
There are numerous products available within the market that aid in the mobility of affected individuals in need. Rapid advancements in technology and growing research and development in medical transportation products and equipment have enabled the accessibility of emergency services to patients in a medical setting.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2017 to 2021 Patient Transportation Market Historic Outlook Compared to 2022 to 2032 Forecast
The market value for patient transportation held nearly 23.3% of the overall US$ 80 Billion healthcare transportation market in 2021.
Growing accessibility of patient transportation equipment through local service providers, along with the rising initiatives by government authorities regarding safety guidelines and regulations with respect to medical equipment and its utilization are driving sales in the market.
In the event of an emergency, providing assistive equipment and aids for transportation has proven to be critical in preventing adverse outcomes that could result in death or serious patient trauma. Furthermore, the increasing incidence of immobility among patients due to chronic diseases, disability, external injuries, and inherited disorders is underpinning the need for effective patient transportation solutions.
In the healthcare sector, there have been numerous breakthroughs and introductions of new and innovative initiatives to improve the quality of comprehensive patient care. In both emergency and non-emergency situations, many countries have developed affordable and accessible ambulatory care services and emergency services to aid with patient transportation.
Patient transportation has been more accessible in developing countries due to the presence of well-established healthcare infrastructure. Furthermore, the high prevalence of chronic diseases and the growing establishment of senior homes are spurring demand in the market.
The scope of usage and adoption within the patient transportation market is determined by regulations governing the spectrum of patient transportation equipment, technologies, tools, and services.
The availability of reimbursements for patient transportation, as well as insurance coverage for emergency medical transportation, will augment the growth in the market in the forthcoming years.
Sales in the patient transportation market are slated to grow at a 5.9% CAGR, offering an absolute $ opportunity of US$ 1.2 Billion over the forecast period.
What are the Key Opportunities For Patient Transportation Market Players?
The global patient transportation market is anticipated to benefit from product innovations with improved capabilities. Incorporating new technology into emerging countries' existing healthcare systems can help to accelerate the development of improved solutions that solve the issue of resource availability for an efficient patient transportation process.
According to the United Nations' World Population Ageing Database in 2020, the global geriatric population is predicted to rise from 727 million in 2020 to 1.5 billion by 2050. Due to the aging population's susceptibility to fall-related injuries that can develop into functional disabilities, healthcare professionals and caregivers are using patient transportation solutions.
Further, the high prevalence of obesity and the bariatric population is underpinning the need for mobility solutions. Specialized equipment such as beds, support surfaces, and bariatric lifts and chairs promote patient safety and effective transportation while providing caregivers with safe handling of their associated patients.
The introduction of patient-group-specific transportation solutions will continue fueling the growth in the market over the forecast period.
Find your sweet spots for generating winning opportunities in this market.
What Factors are Limiting Sales of Patient Transportation Solutions?
Growth in the market is hampered by several factors including the high cost associated with patient transportation equipment, low accessibility in rural areas, and the availability of substitute products.
Low awareness regarding the availability of non-emergency patient transportation in developing nations will further restrain the demand for patient transportation solutions.
Presently, owing to cost reduction initiatives being implemented within hospital settings across many developing as well as developed economies, there is a limited practice of providing training and drill sessions for effective patient handling and transportation.
Since the initial cost of equipment and maintenance is high, training sessions may pose a financial burden upon healthcare institutions, mainly within countries falling under developing economies.
Country-wise Insights
What Makes the USA Patient Transportation Market Attractive?
Surging Demand for Assistive Equipment in the Healthcare Sector Will Fuel Growth
The USA is anticipated to dominate the North American patient transformation market, with demand growing at a 6.3% CAGR over the assessment period. The USA has a well-defined healthcare infrastructure wherein the services and products associated with patient safety and emergency patient transportation are readily accessible.
The presence of a centralized hotline for healthcare-related emergencies, and the allocation of reimbursements for a range of several medical events will continue pushing sales in the market over the forecast period.
What is Driving the Germany Patient Transportation Market?
Growing Need for Emergency Medical Transportation in Germany Will Spur Demand
Sales in Germany are forecast to increase at a 6.0% CAGR, leading theEurope patient transportation market during the forecast period. Growth can be attributed to high prevalence of the older which necessitates provisions regarding health and patient safety, and technological advancements in patient transportation products, such as specialized chairs for bariatric patients.
Will China Continue Dominating the East Asia Patient Transportation Market?
Increasing Accessibility of Patient Transportation in China Will Boost Sales
Demand in the China market is projected to gain traction at a 5.9% CAGR through 2032. The country is expected to emerge as a lucrative pocket amid growing investments in healthcare infrastructure, along with the availability of subsidized pricing in reimbursement policies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which is the Leading Application of Patient Transportation?
Sales of Non-Emergency Patient Transportation Will Gain Impetus
The non-emergency transportation segment accounted for about 47.4% of the total market share in 2021 and is expected to continue its dominance over the forecast period. The presence of non-emergency transportation is a significant social indicator of health. Transportation barriers are prominent between many low-income patients and patients from racial and ethnic minorities, perpetuating healthcare disparities.
Alternative solutions, such as rideshare-based non-emergency transportation systems, have improved outcomes such as appointment attendance rates, overall wait times, and cost. Driven by this, sales in this segment will continue gaining traction in the forthcoming years.
Which End User Benefits the Most from the Employment of Patient Transportation?
Demand for Patient Transportation Solutions in Hospitals Remains High
In terms of end users, the hospital's segment held 45.9% of the total market share In 2021. Vendors and manufacturers work with hospitals and healthcare facilities to upgrade or maintain their patient transportation equipment.
The availability of patient transportation equipment through alliances and tie-ups with other medical care facilities has extended the reach of services related to patient transportation. As a result of accessible and improved solutions for comprehensive patient care, sales in this segment are forecast to grow at a considerable pace.
Competitive Landscape
Leading players operating in the global patient transportation market are aiming to gain a competitive advantage in the market by extending their product portfolio and investing in mergers and acquisitions to bring vital healthcare supplies closer to patients, as well as trade partners. The cost of new technology and infrastructure, as well as the start-up and fit-out of new or enlarged activities, are all a part of the investment. For instance:
In February 2022, DHL Supply Chain, a division of Deutsche Post DHL Group, stated that its Life Sciences and Healthcare sector will invest upwards of $400 million this year to increase its medical device and pharmaceutical footprint of distribution network by 27%, which accounts for roughly 3 million square feet. DHL Supply Chain's latest investment comprises six additional USA locations by the end of 2022.
In May 2020, The Providence Service stated that its subsidiary, LogistiCare Solutions, LLC, had acquired National MedTrans from Specialty Benefits, LLC, which included its ongoing contractual connections to offer non-emergency medical transportation.
Report Scope as per Patient Transportation Industry Analysis
Attributes
Details
Forecast Period
2022 to 2032
Historical Data Available for
2017 to 2021
Market Analysis
US$ Million for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
The USA, Canada, Brazil, Mexico, Argentina, Germany, The UK, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Turkey, and South Africa
Key Market Segments Covered
Application, End User, and Region
Pricing
Available upon Request
Key Market Players
DHL Healthcare
ATS Healthcare Solutions
Xpress Non-Emergency Medical Transportation
Logisticare
American Medical Response
ProHealth Care
Watts Healthcare
AMR
ERS Transition Ltd.
ModivCare Solutions, LLC
Goodfaith Medical Transportation Company, Inc.
Hope Medical Transportation Service LLC
Falck A/S
National Medtrans Network
Air Methods Corporation
Envision Healthcare Corporation
Acadian
NSL Limited
Airmed International LLC
Airpal, Inc
Key Market Segments Covered in Patient Transportation Industry Research
By Application:
Emergency
Non-Emergency
Mental Health Transport
Intensive Care Patient Transport
Others
Non-Medical Transportation
Medical Repatriation Services
Event Covers
Others
By End-User:
Hospitals
Medical Centres
Retirement Communities
Hospice Care Facilities
Private Paying Customers
Nursing Care Facilities
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
How much is the patient transportation market currently worth?
The global patient transportation market size is projected to reach US$ 19.7 Million in 2022, and is set to expand 1.8X over the next ten years.
What is the sales forecast for patient transportation through 2032?
The patient transportation market is expected to reach US$ 35.1 Million by the end of 2032, with sales growing at a 5.9% CAGR.
What are the key trends shaping the patient transportation industry?
The rising geriatric population and increasing prevalence of chronic diseases such as diabetes and obesity leading to mobility issues are some of the key trends spurring demand in the market.
Which are the top 5 countries driving demand for patient transportation?
The USA, Germany, UK, India, and France are expected to drive demand for patient transportation products.
What is the North America market outlook for patient transportation?
North America is one of the key markets for patient transportation, with the USA accounting for about 32.0% market share in the global market in 2021.
At what rate will the demand for patient transportation increase in Europe?
Demand for patient transportation in Europe is expected to register a 5.9% CAGR over the assessment period.
Which are key countries for the patient transportation market?
The USA, Germany and India are the key producers in the patient transportation market.
Table of Content
1. Executive Summary | Patient Transportation Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Assessment
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Expenditure Outlook
4.1.3. Growth of the Healthcare Sector in Emerging Nations
4.2. Forecast Factors - Relevance & Impact
4.2.1. Adoption of Application
4.2.2. Rise in Emergency Medical Situations
4.2.3. Cost of Service Care
4.2.4. Strategic Collaborations
4.2.5. Rise of healthcare spending in developing economies
4.2.6. Growing Number of Service Providers
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. COVID-19 Crisis Analysis
5.1. COVID-19 and Impact Analysis
5.1.1. Revenue By Application
5.1.2. Revenue By End User
5.1.3. Revenue By Region
5.2. 2021 Market Scenario
6. Key Success Factors
6.1. Service Adoption/ Usage Analysis
6.2. Key Promotional Strategies, By Key Manufacturers
6.3. Regulatory Scenario
6.4. Reimbursement Scenario
6.5. Impact of Technology Advancements on Patient Transport Application
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
7.2. Current and Future Market Size (US$ Million) and Forecast Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) By Application, 2012 to 2021
8.3. Current and Future Market Size (US$ Million) and Forecast By Application, 2022 to 2032
8.3.1. Emergency
8.3.2. Non-Emergency
8.3.2.1. Mental Health Transport
8.3.2.2. Intensive Care Patient Transport
8.3.2.3. Others
8.3.3. Non-Medical Transportation
8.3.3.1. Medical Repatriation Application
8.3.3.2. Event Covers
8.3.3.3. Others
8.4. Market Attractiveness Analysis By Application
9. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) By End User, 2012 to 2021
9.3. Current and Future Market Size (US$ Million) and Forecast By End User, 2022 to 2032
9.3.1. Hospitals
9.3.2. Medical Centers
9.3.3. Retirement Communities
9.3.4. Hospice Care Facilities
9.3.5. Private Paying Customers
9.3.6. Nursing Care Facilities
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) and By Region, 2012 to 2021
10.3. Current and Future Market Size (US$ Million) and Forecast By Region, 2022 to 2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
11.1. Introduction
11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2021
11.3. Current and Future Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2032
11.3.1. By Country
11.3.1.1. United States of America
11.3.1.2. Canada
11.3.2. By Application
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Application
11.4.3. By End User
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
11.8. Country-Level Analysis & Forecast
11.8.1. USA Market Analysis
11.8.1.1. .Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Application
11.8.1.2.2. By End User
11.8.2. Canada Market Analysis
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Application
11.8.2.2.2. By End User
12. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2021
12.3. Current and Future Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2032
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Application
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Application
12.4.3. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country-Level Analysis & Forecast
12.8.1. Brazil Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Application
12.8.1.2.2. By End User
12.8.2. Mexico Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Application
12.8.2.2.2. By End User
12.8.3. Argentina Market Analysis
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast by Market Taxonomy
12.8.3.2.1. By Application
12.8.3.2.2. By End User
13. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2021
13.3. Current and Future Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2032
13.3.1. By Country
13.3.1.1. United Kingdom
13.3.1.2. Germany
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Nordic Countries and Russia
13.3.1.8. Rest of Europe
13.3.2. By Application
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Application
13.4.3. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country-Level Analysis & Forecast
13.8.1. UK Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Application
13.8.1.2.2. By End User
13.8.2. Germany Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Application
13.8.2.2.2. By End User
13.8.3. France Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Application
13.8.3.2.2. By End User
13.8.4. Italy Market Analysis
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Application
13.8.4.2.2. By End User
13.8.5. Spain Market Analysis
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Application
13.8.5.2.2. By End User
13.8.6. BENELUX Market Analysis
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Application
13.8.6.2.2. By End User
13.8.7. Nordic Countries and Russia Market Analysis
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Application
13.8.7.2.2. By End User
14. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Trend Analysis By Market Taxonomy, 2012 to 2021
14.3. Current and Future Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Application
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Application
14.4.3. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. India Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Application
14.8.1.2.2. By End User
14.8.2. Indonesia Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Application
14.8.2.2.2. By End User
14.8.3. Malaysia Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Application
14.8.3.2.2. By End User
14.8.4. Thailand Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Application
14.8.4.2.2. By End User
15. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2021
15.3. Current and Future Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Application
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Application
15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. China Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Application
15.8.1.2.2. By End User
15.8.2. Japan Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Application
15.8.2.2.2. By End User
15.8.3. South Korea Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Application
15.8.3.2.2. By End User
16. Oceania Market Analysis 2012 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Application
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Application
16.4.2. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. Australia Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Application
16.8.1.2.2. By End User
16.8.2. New Zealand Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Application
16.8.2.2.2. By End User
17. Middle East & Africa Market Analysis 2012 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Trend Analysis By Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. Turkey
17.3.1.2. GCC Countries
17.3.1.3. North Africa
17.3.1.4. South Africa
17.3.1.5. Rest of MEA
17.3.2. By Application
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Application
17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. Turkey Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Application
17.8.1.2.2. By End User
17.8.2. GCC Countries Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Application
17.8.2.2.2. By End User
17.8.3. North Africa Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Application
17.8.3.2.2. By End User
17.8.4. South Africa Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Application
17.8.4.2.2. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional Footprint of Players
18.4.2. Service Footprint by Players
18.4.3. Channel Footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1.1. DHL Healthcare
19.3.1.1.1. Overview
19.3.1.1.2. Component Portfolio
19.3.1.1.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.1.4. Sales Footprint
19.3.1.1.5. Strategy Overview
19.3.1.1.5.1. Marketing Strategies
19.3.1.1.5.2. Channel Strategies
19.3.1.1.5.3. Service Strategies
19.3.1.2. Healthcare Solutions
19.3.1.2.1. Overview
19.3.1.2.2. Component Portfolio
19.3.1.2.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.2.4. Sales Footprint
19.3.1.2.5. Strategy Overview
19.3.1.2.5.1. Marketing Strategies
19.3.1.2.5.2. Channel Strategies
19.3.1.2.5.3. Service Strategies
19.3.1.3. Xpress Non-Emergency Medical Transportation
19.3.1.3.1. Overview
19.3.1.3.2. Component Portfolio
19.3.1.3.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.3.4. Sales Footprint
19.3.1.3.5. Strategy Overview
19.3.1.3.5.1. Marketing Strategies
19.3.1.3.5.2. Channel Strategies
19.3.1.3.5.3. Service Strategies
19.3.1.4. Logisticare
19.3.1.4.1. Overview
19.3.1.4.2. Component Portfolio
19.3.1.4.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.4.4. Sales Footprint
19.3.1.4.5. Strategy Overview
19.3.1.4.5.1. Marketing Strategies
19.3.1.4.5.2. Channel Strategies
19.3.1.4.5.3. Service Strategies
19.3.1.5. American Medical Response
19.3.1.5.1. Overview
19.3.1.5.2. Component Portfolio
19.3.1.5.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.5.4. Sales Footprint
19.3.1.5.5. Strategy Overview
19.3.1.5.5.1. Marketing Strategies
19.3.1.5.5.2. Channel Strategies
19.3.1.5.5.3. Service Strategies
19.3.1.6. ProHealth Care
19.3.1.6.1. Overview
19.3.1.6.2. Component Portfolio
19.3.1.6.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.6.4. Sales Footprint
19.3.1.6.5. Strategy Overview
19.3.1.6.5.1. Marketing Strategies
19.3.1.6.5.2. Channel Strategies
19.3.1.6.5.3. Service Strategies
19.3.1.7. Watts Healthcare
19.3.1.7.1. Overview
19.3.1.7.2. Component Portfolio
19.3.1.7.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.7.4. Sales Footprint
19.3.1.7.5. Strategy Overview
19.3.1.7.5.1. Marketing Strategies
19.3.1.7.5.2. Channel Strategies
19.3.1.7.5.3. Service Strategies
19.3.1.8. AMR
19.3.1.8.1. Overview
19.3.1.8.2. Component Portfolio
19.3.1.8.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.8.4. Sales Footprint
19.3.1.8.5. Strategy Overview
19.3.1.8.5.1. Marketing Strategies
19.3.1.8.5.2. Channel Strategies
19.3.1.8.5.3. Service Strategies
19.3.1.9. ERS Transition Ltd.
19.3.1.9.1. Overview
19.3.1.9.2. Component Portfolio
19.3.1.9.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.9.4. Sales Footprint
19.3.1.9.5. Strategy Overview
19.3.1.9.5.1. Marketing Strategies
19.3.1.9.5.2. Channel Strategies
19.3.1.9.5.3. Service Strategies
19.3.1.10. ModivCare Solutions, LLC
19.3.1.10.1. Overview
19.3.1.10.2. Component Portfolio
19.3.1.10.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.10.4. Sales Footprint
19.3.1.10.5. Strategy Overview
19.3.1.10.5.1. Marketing Strategies
19.3.1.10.5.2. Channel Strategies
19.3.1.10.5.3. Service Strategies
19.3.1.11. Goodfaith Medical Transportation Company, Inc.
19.3.1.11.1. Overview
19.3.1.11.2. Component Portfolio
19.3.1.11.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.11.4. Sales Footprint
19.3.1.11.5. Strategy Overview
19.3.1.11.5.1. Marketing Strategies
19.3.1.11.5.2. Channel Strategies
19.3.1.11.5.3. Service Strategies
19.3.1.12. Hope Medical Transportation Service LLC
19.3.1.12.1. Overview
19.3.1.12.2. Component Portfolio
19.3.1.12.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.12.4. Sales Footprint
19.3.1.12.5. Strategy Overview
19.3.1.12.5.1. Marketing Strategies
19.3.1.12.5.2. Channel Strategies
19.3.1.12.5.3. Service Strategies
19.3.1.13. Falck A/S
19.3.1.13.1. Overview
19.3.1.13.2. Component Portfolio
19.3.1.13.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.13.4. Sales Footprint
19.3.1.13.5. Strategy Overview
19.3.1.13.5.1. Marketing Strategies
19.3.1.13.5.2. Channel Strategies
19.3.1.13.5.3. Service Strategies
19.3.1.14. National Medtrans Network
19.3.1.14.1. Overview
19.3.1.14.2. Component Portfolio
19.3.1.14.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.14.4. Sales Footprint
19.3.1.14.5. Strategy Overview
19.3.1.14.5.1. Marketing Strategies
19.3.1.14.5.2. Channel Strategies
19.3.1.14.5.3. Service Strategies
19.3.1.15. Air Methods Corporation
19.3.1.15.1. Overview
19.3.1.15.2. Component Portfolio
19.3.1.15.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.15.4. Sales Footprint
19.3.1.15.5. Strategy Overview
19.3.1.15.5.1. Marketing Strategies
19.3.1.15.5.2. Channel Strategies
19.3.1.15.5.3. Service Strategies
19.3.1.16. Envision Healthcare Corporation
19.3.1.16.1. Overview
19.3.1.16.2. Component Portfolio
19.3.1.16.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.16.4. Sales Footprint
19.3.1.16.5. Strategy Overview
19.3.1.16.5.1. Marketing Strategies
19.3.1.16.5.2. Channel Strategies
19.3.1.16.5.3. Service Strategies
19.3.1.17. Acadian
19.3.1.17.1. Overview
19.3.1.17.2. Component Portfolio
19.3.1.17.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.17.4. Sales Footprint
19.3.1.17.5. Strategy Overview
19.3.1.17.5.1. Marketing Strategies
19.3.1.17.5.2. Channel Strategies
19.3.1.17.5.3. Service Strategies
19.3.1.18. NSL Limited
19.3.1.18.1. Overview
19.3.1.18.2. Component Portfolio
19.3.1.18.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.18.4. Sales Footprint
19.3.1.18.5. Strategy Overview
19.3.1.18.5.1. Marketing Strategies
19.3.1.18.5.2. Channel Strategies
19.3.1.18.5.3. Service Strategies
19.3.1.19. Airmed International LLC
19.3.1.19.1. Overview
19.3.1.19.2. Component Portfolio
19.3.1.19.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.19.4. Sales Footprint
19.3.1.19.5. Strategy Overview
19.3.1.19.5.1. Marketing Strategies
19.3.1.19.5.2. Channel Strategies
19.3.1.19.5.3. Service Strategies
19.3.1.20. Airpal, Inc
19.3.1.20.1. Overview
19.3.1.20.2. Component Portfolio
19.3.1.20.3. Profitability by Market Segments (Component/Channel/Region)
19.3.1.20.4. Sales Footprint
19.3.1.20.5. Strategy Overview
19.3.1.20.5.1. Marketing Strategies
19.3.1.20.5.2. Channel Strategies
19.3.1.20.5.3. Service Strategies
20. Assumptions and Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 02: Global Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 03: Global Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
Table 04: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 05: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
Table 06: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 07: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
Table 08: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 09: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
Table 10: Asia Pacific Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 11: Asia Pacific Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
Table 12: Middle East and Africa (MEA) Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 13: Middle East and Africa (MEA) Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Historical Market (US$ Million) Analysis, 2017 to 2021
Figure 02: Global Market Value (US$) & Y-o-Y Growth (%), 2022 to 2032
Figure 03: Global Market Absolute $ Opportunity, 2022 to 2032
Figure 04: Global Market Share Analysis (%) By Application, 2022 & 2032
Figure 05: Global Market Y-o-Y Growth (%) By Application, 2022 to 2032
Figure 06: Global Market Attractiveness Analysis, By Application
Figure 07: Global Market Share Analysis (%) By End User, 2022 & 2032
Figure 08: Global Market Y-o-Y Growth (%) By End User, 2022 to 2032
Figure 09: Global Market Attractiveness Analysis, By End User
Figure 10: Global Market Share Analysis (%) By Region, 2022 & 2032
Figure 11: Global Market Y-o-Y Growth (%) By Region, 2022 to 2032
Figure 12: Global Market Attractiveness Analysis, By Region
Figure 13: North America Market Value (US$ Million) Analysis, 2021(A) & 2032(F)
Figure 14: North America Market Value (US$ Million) Analysis, by Application, 2022
Figure 15: North America Market Value (US$ Million) Analysis, by End User, 2022
Figure 16: North America Historical Market (US$ Million) Analysis, 2017 to 2021
Figure 17: North America Market Value (US$) & Y-o-Y Growth (%), 2022 to 2032
Figure 18: North America Market Attractiveness Analysis, By Application
Figure 19: North America Market Attractiveness Analysis, By End User
Figure 20: Latin America Market Value (US$ Million) Analysis, 2021(A) & 2032(F)
Figure 21: Latin America Market Value (US$ Million) Analysis, by Application, 2022
Figure 22: Latin America Market Value (US$ Million) Analysis, by End User, 2022
Figure 23: Latin America Historical Market (US$ Million) Analysis, 2017 to 2021
Figure 24: Latin America Market Value (US$) & Y-o-Y Growth (%), 2022 to 2032
Figure 25: Latin America Market Attractiveness Analysis, By Application
Figure 26: Latin America Market Attractiveness Analysis, By End User
Figure 27: Europe Market Value (US$ Million) Analysis, 2021(A) & 2032(F)
Figure 28: Europe Market Value (US$ Million) Analysis, by Application, 2022
Figure 29: Europe Market Value (US$ Million) Analysis, by End User, 2022
Figure 30: Europe Historical Market (US$ Million) Analysis, 2017 to 2021
Figure 31: Europe Market Value (US$) & Y-o-Y Growth (%), 2022 to 2032
Figure 32: Europe Market Attractiveness Analysis, By Application
Figure 33: Europe Market Attractiveness Analysis, By End User
Figure 35: Asia Pacific Market Value (US$ Million) Analysis, by Application, 2022
Figure 36: Asia Pacific Market Value (US$ Million) Analysis, by End User, 2022
Figure 37: Asia Pacific Historical Market (US$ Million) Analysis, 2017 to 2021
Figure 38: Asia Pacific Market Value (US$) & Y-o-Y Growth (%), 2022 to 2032
Figure 39: Asia Pacific Market Attractiveness Analysis, By Application
Figure 40: Asia Pacific Market Attractiveness Analysis, By End User
Figure 41: Middle East and Africa (MEA) Market Value (US$ Million) Analysis, 2021(A) & 2032(F)
Figure 42: Middle East and Africa (MEA) Market Value (US$ Million) Analysis, by Application, 2022
Figure 43: Middle East and Africa (MEA) Market Value (US$ Million) Analysis, by End User, 2022
Figure 44: Middle East and Africa (MEA) Historical Market (US$ Million) Analysis, 2017 to 2021
Figure 45: Middle East and Africa (MEA) Market Value (US$) & Y-o-Y Growth (%), 2022 to 2032
Figure 46: Middle East and Africa (MEA) Market Attractiveness Analysis, By Application
Figure 47: Middle East and Africa (MEA) Market Attractiveness Analysis, By End User
Figure 48: USA Market Share Analysis (%) By Application, 2022 & 2032
Figure 49: USA Market Share Analysis (%) By End User, 2022 & 2032
Figure 50: Canada Market Share Analysis (%) By Application, 2022 & 2032
Figure 51: Canada Market Share Analysis (%) By End User, 2022 & 2032
Figure 52: Mexico Market Share Analysis (%) By Application, 2022 & 2032
Figure 53: Mexico Market Share Analysis (%) By End User, 2022 & 2032
Figure 54: Brazil Market Share Analysis (%) By Application, 2022 & 2032
Figure 55: Brazil Market Share Analysis (%) By End User, 2022 & 2032
Figure 56: India Market Share Analysis (%) By Application, 2022 & 2032
Figure 57: India Market Share Analysis (%) By End User, 2022 & 2032
Figure 58: China Market Share Analysis (%) By Application, 2022 & 2032
Figure 59: China Market Share Analysis (%) By End User, 2022 & 2032
Figure 60: Japan Market Share Analysis (%) By Application, 2022 & 2032
Figure 61: Japan Market Share Analysis (%) By End User, 2022 & 2032
Figure 62: Germany Market Share Analysis (%) By Application, 2022 & 2032
Figure 63: Germany Market Share Analysis (%) By End User, 2022 & 2032
Figure 64: France Market Share Analysis (%) By Application, 2022 & 2032
Figure 65: France Market Share Analysis (%) By End User, 2022 & 2032
Figure 66: Italy Market Share Analysis (%) By Application, 2022 & 2032
Figure 67: Italy Market Share Analysis (%) By End User, 2022 & 2032
Figure 68: Russia Market Share Analysis (%) By Application, 2022 & 2032
Figure 69: Russia Market Share Analysis (%) By End User, 2022 & 2032
Figure 70: GCC Countries Market Share Analysis (%) By Application, 2022 & 2032
Figure 71: GCC Countries Market Share Analysis (%) By End User, 2022 & 2032
Figure 72: South Africa Market Share Analysis (%) By Application, 2022 & 2032
Figure 73: South Africa Market Share Analysis (%) By End User, 2022 & 2032
